Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Patients Diagnosed”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT00326820
What this trial is testing

Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer

Who this might be right for
Breast CancerHypercalcemia of MalignancyMetastatic Cancer
Wales Cancer Trials Unit 1,404
Not applicableEnded earlyNCT02197949
What this trial is testing

Preoperative and Intraoperative Quantification of Axillary Tumoral Load

Who this might be right for
Breast Cancer
Parc de Salut Mar 12
Not applicableUnknownNCT06474988
What this trial is testing

Characterization of Biophysical and Mechanical Parameters on Skin of Breast Cancer Patients

Who this might be right for
Breast CancerEstrogen Receptor Positive Tumor
European Institute of Oncology 150
Not applicableLooking for participantsNCT03787056
What this trial is testing

Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients

Who this might be right for
CancerBreast CancerGastric Cancer+14 more
Hospices Civils de Lyon 410
Testing effectiveness (Phase 2)Study completedNCT05889728
What this trial is testing

Pilot Trial to Assess 68Ga Bombesin PET/CT (NeoB) Imaging for Staging of Breast Cancer

Who this might be right for
Breast Cancer
St Vincent's Hospital, Sydney 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT02876107
What this trial is testing

Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer

Who this might be right for
Breast CarcinomaBreast LumpEdema+8 more
M.D. Anderson Cancer Center 42
Testing effectiveness (Phase 2)WithdrawnNCT03065712
What this trial is testing

Test - Retest Reproducibility of 18F Fluoroestradiol (FES) PET

Who this might be right for
Breast Cancer
University of Texas Southwestern Medical Center
Not applicableStudy completedNCT02019303
What this trial is testing

Accuracy of FNA Versus CNB of Abnormal Axillary Lymph Nodes in Setting of Invasive Breast Cancer

Who this might be right for
Breast Cancer
University of Utah 140
Early research (Phase 1)Ended earlyNCT04060342
What this trial is testing

GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic AdenocarcinomaEsophageal AdenocarcinomaEsophageal Squamous Cell Carcinoma+11 more
GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. 61
Not applicableUnknownNCT05574920
What this trial is testing

Characterizing Breast Cancer With Al18F-NOTA-FAPI-04 PET/CT (PFB-02)

Who this might be right for
Breast Cancer
Peking Union Medical College Hospital 88
Not applicableStudy completedNCT04394247
What this trial is testing

Patient Characteristics, Treatment Patterns, and Clinical Outcomes in Patients Diagnosed With HR+/HER2 Advanced/Metastatic Breast Cancer on Palbociclib + Aromatase Inhibitor (AI) Combination Therapy

Who this might be right for
Breast Cancer
Pfizer 242
Not applicableUnknownNCT04547465
What this trial is testing

2D Speckle-tracking Echocardiography in Chemotherapy-induced Cardiomyopathy With Cardiovascular Risk Factors

Who this might be right for
Cardiomyopathy Due to DrugBreast CancerCardiovascular Risk Factor
Gia Dinh People Hospital 300
Early research (Phase 1)Study completedNCT00003867
What this trial is testing

Irinotecan and Capecitabine in Treating Patients With Solid Tumors

Who this might be right for
Cancer
Montefiore Medical Center 30
Early research (Phase 1)Active Not RecruitingNCT03168737
What this trial is testing

18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in Patients

Who this might be right for
Malignant Breast NeoplasmMalignant Colorectal NeoplasmMalignant Pancreatic Neoplasm+1 more
M.D. Anderson Cancer Center 25
Not applicableLooking for participantsNCT06878547
What this trial is testing

VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker: Evaluation of Anisotropy in Cancer Patients

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 250
Not applicableLooking for participantsNCT07823660
What this trial is testing

Cardio-Oncology Rehabilitation in Breast Cancer Patients Undergoing Chemotherapy

Who this might be right for
Breast Cancer
Hospital de Clinicas de Porto Alegre 30
Not applicableStudy completedNCT05011409
What this trial is testing

Prevalence of Depression and Anxiety Among Breast Cancer Patients

Who this might be right for
DepressionAnxietyBreast Cancer
Kazakh Medical University of Continuing Education 162
Not applicableUnknownNCT02479100
What this trial is testing

Contrast Enhanced Spectral Mammography (CESM) Study

Who this might be right for
Breast Cancer
Cambridge University Hospitals NHS Foundation Trust 103
Not applicableUnknownNCT04987424
What this trial is testing

Prevalence of Lymphedema in Valle Del Cauca, Colombia.

Who this might be right for
Unilateral Breast Cancer
Grupo de investigación C.E.R 367
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07523607
What this trial is testing

FAP PET/CT for Staging Patients With Breast Cancer

Who this might be right for
Breast Cancer Detection
Odense University Hospital 65
Next Page